YHGJHIGH SIGNALFINANCIAL10-K

YHGJ reported substantially deteriorated net losses alongside declining revenue and a significantly weakened cash position, indicating serious financial distress.

The company's financial condition has meaningfully deteriorated with revenue declining 12.5% year-over-year while losses expanded substantially. The cash position dropped by over half to just $97K while debt increased 44% to $7M, creating a concerning liquidity situation that threatens operational sustainability.

Comparing 2026-03-23 vs 2025-04-15View on EDGAR →
FINANCIAL ANALYSIS

YHGJ's financial performance weakened across multiple fronts, with revenue falling 12.5% to $56.2M while net losses expanded substantially to $2.5M. The balance sheet deteriorated meaningfully as cash dropped from $220K to just $97K while total debt grew 44% to $7M, compressing stockholders' equity by 20%. Operating cash flow improved modestly but remained negative, providing little relief given the company's precarious liquidity position.

FINANCIAL STATEMENT CHANGES
Operating Cash Flow
Cash Flow
+86.5%
-$1.3M→-$172K

Operating cash flow surged 86.5% — exceptional cash generation, highest quality earnings signal.

Net Income
P&L
-68.8%
-$1.5M→-$2.5M

Net income declined 68.8% — review whether driven by operations, interest costs, or non-recurring items.

Cash & Equivalents
Balance Sheet
-55.9%
$220K→$97K

Cash declined 55.9% — significant cash burn or deployment; verify adequacy of remaining liquidity runway.

Capital Expenditure
Cash Flow
+49.8%
$221K→$331K

Capital expenditure jumped 49.8% — major investment cycle underway; assess returns on deployment.

Total Debt
Balance Sheet
+44.2%
$4.9M→$7.0M

Debt increased 44.2% — substantial leverage increase; assess whether deployed for growth or covering losses.

Interest Expense
P&L
+39.6%
$450K→$628K

Interest expense surged 39.6% — significant debt increase or rising rates materially impacting earnings.

Stockholders Equity
Balance Sheet
-20.1%
$10.7M→$8.6M

Equity decreased 20.1% — buybacks or losses reducing book value, monitor solvency ratios.

Revenue
P&L
-12.5%
$64.3M→$56.2M

Revenue softened 12.5% — monitor whether this is cyclical or structural.

Total Assets
Balance Sheet
-12.2%
$25.6M→$22.5M

Total assets contracted 12.2% — asset sales, write-downs, or balance sheet optimization underway.

Accounts Receivable
Balance Sheet
+10.2%
$5.4M→$6.0M

Receivables grew 10.2% — monitor days sales outstanding for collection efficiency.

LANGUAGE CHANGES
NEW — 2026-03-23
PRIOR — 2025-04-15
ADDED
The 2025 Proxy Statement, or an amendment to this Form 10-K, will be filed with the SEC within 120 days after December 31, 2025.
7A Quantitative and Qualitative Disclosures Regarding Market Risk 19 Item No.
10 Directors and Executive Officers of the Registrant 20 Item No.
13 Certain Relationships and Related Transactions 30 Item No.
14 Principal Accounting Fees and Services 30 Part IV Item No.
In 2025, our revenues from our product lines, as a percentage of total revenues were: Novelty Products 65% of revenues Flexible Film Products 6% of revenues Balloon-inspired gifts and Other Products 29% of revenues We are an Illinois corporation with our principal offices and plant at 22160 N.
We entered into a credit facility during September 2021 that was extended during 2025 expiring April 2028.
International Operations The Company formed a wholly owned subsidiary, Yunhong Technology (Hubei) Co., Ltd., in Hubei Province, China (the China subsidiary ) to support its international production operations.
On June 30, 2024, through this subsidiary, the Company acquired certain production equipment and related manufacturing assets pursuant to an Asset Purchase Agreement.
The consideration consisted of 500,000 shares of the Company s common stock, valued at approximately $6.25 million at the time of issuance.
REMOVED
The 2024 Proxy Statement, or an amendment to this Form 10-K, will be filed with the SEC within 120 days after December 31, 2024.
7A Quantitative and Qualitative Disclosures Regarding Market Risk 20 Item No.
10 Directors and Executive Officers of the Registrant 21 Item No.
13 Certain Relationships and Related Transactions 31 Item No.
14 Principal Accounting Fees and Services 31 Part IV Item No.
In 2024, our revenues from our product lines, as a percent of total revenues were: Novelty Products 64% of revenues Flexible Film Products 5% of revenues Balloon-inspired gifts and Other Products 31% of revenues We are an Illinois corporation with our principal offices and plant at 22160 N.
Cesario rejoined the Company as Chief Executive Officer and Acting Chief Financial Officer until November 2024 when he resigned from his employee positions but retained his role on the Board of Directors.
We entered into a credit facility during September 2021 that was extended during 2023 expiring September 2025.
Beginning November 2018, the Company experienced severe difficulty in securing adequate seasonal workers in its US operations, forcing it to pay substantially higher costs in the form of overtime and a holiday premium.
International Operations The Company formed a wholly owned subsidiary, Yunhong Technology (Hubei) Co.
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →